home / stock / tlppf / tlppf short
Short Information | Telix Pharmaceuticals Ltd (OTCMKTS:TLPPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 107,052 |
Total Actual Volume | 125,384 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 15 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 5,353 |
Average Short Percentage | 73.28% |
Is there a TLPPF Short Squeeze or Breakout about to happen?
See the TLPPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-30-2024 | $10.79 | $10.908 | $11 | $10.65 | 5,361 | 5,361 | 100% |
05-29-2024 | $10.51 | $10.76 | $10.77 | $10.51 | 4,029 | 4,029 | 100% |
05-28-2024 | $10.63 | $10.6 | $10.63 | $10.45 | 20,113 | 20,113 | 100% |
05-24-2024 | $10.05 | $10.45 | $10.5 | $10.05 | 7,482 | 5,623 | 75.15% |
05-23-2024 | $10.275 | $10.3 | $10.5 | $10.2 | 4,002 | 3,502 | 87.51% |
05-22-2024 | $10.61 | $10.81 | $10.81 | $10.61 | 5,040 | 4,000 | 79.37% |
05-21-2024 | $10.56 | $10.32 | $10.56 | $10.32 | 12,920 | 12,870 | 99.61% |
05-20-2024 | $10.57 | $10.79 | $10.79 | $10.2 | 12,140 | 12,140 | 100% |
05-17-2024 | $10.25 | $10.18 | $10.5 | $9.6 | 2,960 | 1,850 | 62.5% |
05-16-2024 | $10.81 | $10.44 | $10.81 | $10.44 | 3,272 | 2,772 | 84.72% |
05-15-2024 | $10.3 | $10.21 | $10.3 | $10.1 | 3,700 | 1,700 | 45.95% |
05-14-2024 | $10.245 | $10.2 | $10.2495 | $10.2 | 3,619 | 1,192 | 32.94% |
05-13-2024 | $10.372 | $10.2 | $10.505 | $10.2 | 4,746 | 4,646 | 97.89% |
05-10-2024 | $10.485 | $10.2 | $10.485 | $10.2 | 280 | 150 | 53.57% |
05-09-2024 | $10.175 | $10.18 | $10.18 | $10.175 | 600 | 100 | 16.67% |
05-08-2024 | $9.61 | $10.1 | $10.1 | $9.61 | 4,550 | 1,550 | 34.07% |
05-07-2024 | $10.22 | $10 | $10.22 | $9.99 | 1,454 | 254 | 17.47% |
05-06-2024 | $10.2925 | $9.96 | $10.4 | $9.96 | 8,113 | 7,692 | 94.81% |
05-03-2024 | $0 | $9.95 | $0 | $0 | 80 | 80 | 100% |
05-02-2024 | $9.5 | $9.95 | $10 | $9.5 | 20,923 | 17,428 | 83.3% |
News, Short Squeeze, Breakout and More Instantly...
Telix Pharmaceuticals Ltd Company Name:
TLPPF Stock Symbol:
OTCMKTS Market:
TLX591 is an investigational anti-PSMA 1 radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen. Reported median radiographic progression-free survival (rPFS) is 8.8 months. Builds on prior data from...
MELBOURNE, Australia, May 28, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit (“...
CUPID is a Phase I safety and dosimetry study of TLX592, Telix’s investigational antibody-based targeted alpha therapy for prostate cancer. Establishes proof-of-concept for Telix’s proprietary RADmAb® engineered antibody platform, currently under pre-clinical evaluation for...